Botox competitor awaits approval
The FDA has agreed to evaluate an anti-wrinkle injection treatment from France-based pharmaceutical company Ipsen which if approved would provide a rival for Allergan's Botox.
News & Analysis on Cosmetics Innovation
The FDA has agreed to evaluate an anti-wrinkle injection treatment from France-based pharmaceutical company Ipsen which if approved would provide a rival for Allergan's Botox.
The beauty market for girls aged between eight and 12 is worth an estimated $500m and includes products as adult seeming as firming cellulite cream, according to NPD Group's latest report.
Fake cosmetics flooded into the EU in ever increasing numbers last year although customs officials seized fewer goods overall.